|

Reflexo Therapy for Gestational Diabetes Mellitus

RECRUITINGN/ASponsored by Kafrelsheikh University
Actively Recruiting
PhaseN/A
SponsorKafrelsheikh University
Started2025-05-01
Est. completion2026-01-01
Eligibility
Age20 Years – 35 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06976164

Summary

The purpose of this study will be to detect the effects of Reflexo therapy of sole on GDM.

Eligibility

Age: 20 Years – 35 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

1. They were maternally aged between 20 and 35 years.
2. The gestational age ranged from between 24 and 36 weeks.
3. Their BMI didn't exceed 30 kg/m2.
4. A singleton live fetus and not under stressful event.

Exclusion Criteria

1. They had high-risk pregnancies.
2. Bad obstetric situations.
3. Diseases that could interfere with participation.
4. Smoking.
5. Oral sedative administration.

Conditions2

DiabetesPhysical Therapy

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.